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Hypoxia Protects Rat Bone Marrow Mesenchymal
Stem Cells Against Compression-Induced Apoptosis
in the Degenerative Disc Microenvironment
Through Activation of the HIF-1a/YAP Signaling Pathway
Zhe Wang,1 Min Cui,1 Yanji Qu,2 Ruijun He,3 Wei Wu,1 Hui Lin,1 and Zengwu Shao1
Stem cell therapy provides an attractive solution for intervertebral disc (IVD) degeneration. However, the
degenerative microenvironment, characterized by excessive mechanical loading and hypoxia, remains an
obstacle for the long-lasting survival of exogenous transplanted stem cells. Whether and how bone marrow
mesenchymal stem cells (BMSCs) adapt to the hostile microenvironment remain unclear. In this study,
CoCl2 and mechanical compression were simultaneously used to simulate the hypoxic and overloaded
microenvironment of IVDs in vitro. Compression had a proapoptotic effect through activation of the
mitochondrial apoptotic pathway, while hypoxia exerted a prosurvival effect counteracting compression-
induced apoptosis. Inhibiting the transcriptional activity of hypoxia inducible factor 1 subunit alpha (HIF-
1a) by chetomin reversed the antiapoptotic effect of hypoxia. Furthermore, HIF-1a promoted dephos-
phorylation and activation of yes-associated protein (YAP) in hypoxic conditions. Conversely, both YAP
inhibition and increased cell apoptosis were observed after inhibition through chetomin or YAP inhibitor
verteporfin. Immunofluorescence staining and coimmunoprecipitation assays revealed that YAP could
interact directly with HIF-1a and colocalize in the nucleus. Taken together, our results demonstrated that
hypoxia protected BMSCs against compression-induced apoptosis in the degenerative disc microenvi-
ronment through activation of the HIF-1a/YAP signaling pathway. Thus, regulation of HIF-1a/YAP sig-
naling might provide novel insights for promoting long-lasting BMSC survival and optimizing stem cell
therapy for IVD degeneration.
Keywords: intervertebral disc degeneration, bone marrow mesenchymal stem cells, hypoxia, apoptosis,
HIF-1a, YAP
Introduction
Intervertebral disc degeneration (IVDD) is the pri-mary cause of chronic low back pain, leading to patient
disability and heavy social burden worldwide [1,2]. Stem cell
therapy-based approaches offer an attractive solution for
IVDD [3,4]. In particular, bone marrow mesenchymal stem
cells (BMSCs) are recognized as excellent graft cells for
intervertebral disc (IVD) regeneration due to their self-
renewal capacity, multilineage differentiation potential, anti-
inflammatory properties, and nonimmunogenic nature [5,6].
Numerous studies using autologous BMSCs for intradiscal
transplantation to treat IVD degenerative diseases have
shown encouraging outcomes, including improvements in the
LBP score, retention of hydration in IVDs, and discogenic
pain reduction in animal models and clinical trials [7–9].
However, the longest reported survival time of transplanted
BMSCs in the degenerative disc was 8 months [10]. Recent
studies have shown the existence of stem/progenitor cells
within the IVD, suggestive of good prospects for endogenous
IVD repair [11–14]. Despite promising preclinical results
of stem cell therapy for IVDD, the challenge of the harsh
microenvironment, which may not support the long-lasting
survival of transplanted cells, remains [15].
During the course of IVDD, excessive mechanical load-
ing, hypoxia, acidic conditions, and nutrient deprivation
create a hostile microenvironment for resident cells while
also compromising the regenerative efficacy of transplanted
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cells [4]. In particular, excessive mechanical loading has
been considered a central contributor to extracellular matrix
(ECM) degradation, intrinsic cell death, and IVDD initia-
tion [16]. Accordingly, excessive compression may also
challenge the survival of transplanted cells [17,18]. Cells
transplanted into the avascular IVD have to adapt to the
low-oxygen environment [5]. In hypoxic conditions, trans-
planted BMSCs maintain stemness, exhibit higher migration
capacity, and are more resistant to apoptosis [19,20]. Hy-
poxia inducible factor 1 subunit alpha (HIF-1a) is the major
transcriptional factor that activates the adaptive cellular
response to hypoxia [21]. Previous studies have revealed the
essential role of HIF-1a in cell survival and matrix syn-
thesis in the nucleus pulposus (NP) [21,22]. Therefore, it is
worthwhile to investigate the role of HIF-1a on transplanted
BMSCs in hypoxia and compression.
Yes-associated protein (YAP) is a transcriptional coacti-
vator in the Hippo signaling pathway. It plays prominent
roles in tissue homeostasis, repair, and regeneration through
regulation of stem cell proliferation and apoptosis [23–25].
Dephosphorylation and nuclear localization of YAP are re-
quired for its activation. Subsequently, YAP interacts with
several DNA-binding transcription factors to induce the
expression of target genes that control cell fate [26,27]. Recent
studies have revealed the role of YAP dysregulation in pro-
gression of IVDD [28,29]. In addition, hypoxic cell survival is
closely related to activation of YAP and its antiapoptotic
target genes [30]. Therefore, YAP activation may be involved
in hypoxic regulation of BMSCs under compression.
The aim of the current study was to investigate the effect
of hypoxia on BMSCs under compression and the under-
lying regulatory mechanism. We reported the essential role
of HIF-1a, which through its interaction with YAP in the
nucleus, promoted BMSC survival in a degenerative disc
microenvironment. Our findings might offer new directions
for optimizing stem cell-based therapy for IVDD.
Materials and Methods
Cell isolation and culture
The experimental procedures were approved by the
Animal Experimentation Committee of Tongji Medical
College and conformed to the Guide for the Care and Use
of Laboratory Animals. Rat BMSCs were isolated from
8-week-old female Sprague-Dawley rats as described pre-
viously with some modifications [31]. Briefly, BMSCs were
collected by flushing the bone marrow with a sterile sy-
ringe from femurs of rats after sacrifice. The bone marrow
was suspended in growth medium containing DMEM/F12
medium (Gibco) supplemented with 10% fetal bovine serum
(FBS; Gibco) and 1% penicillin–streptomycin (Gibco) and
maintained in 25-cm2 culture flasks at 37C in a humidified
atmosphere containing 5% CO2. Complete medium was
replaced every 2 days and cells in passage two were used for
subsequent experiments.
Multilineage differentiation assay
To assess the multilineage differentiation potential of
BMSCs, osteogenic, adipogenic, and chondrogenic differ-
entiation was induced. Briefly, BMSCs were seeded on
24-well plates at 2 · 104 cells/cm2 with complete medium.
For osteogenic induction, BMSCs that reached 70% con-
fluency were induced with the osteogenic differentiation
medium (Cyagen). The medium was changed every other
day, and calcium nodules were stained with Alizarin Red
after 3 weeks of induction. For adipogenic induction, BMSCs
that reached complete confluency were induced with adipo-
genic differential medium A (Cyagen) for 3 days and then
maintained with adipogenic differential medium B (Cyagen)
for 1 day. After 4 cycles, the cells were cultured with me-
dium B for 6 days and lipid droplets were then stained with
Oil Red O. For chondrogenic induction, BMSCs that reached
70% confluency were induced with the chondrogenic dif-
ferentiation medium (Cyagen) containing 1% TGF-b3. The
medium was changed every 3 days, and glycosaminoglycan
was stained with Alcian Blue after 3 weeks of induction. The
typical images were obtained with an inversion microscope
(Olympus IX71, Japan).
Surface marker identification of BMSCs
The first passage BMSCs were suspended at 106 cells/mL
in PBS and aliquoted into 200mL per tube. Cells were in-
cubated with a working solution of antibodies, mouse anti-
CD105 (Abcam; ab11414), mouse anti-CD90 (BD; 554897),
mouse anti-CD73 (BD; 551123), rabbit anti-CD34 (Abcam;
ab81289), mouse anti-CD45 (BD; 740515), and rabbit anti-
HLA-DR (Bioss, bs-1198R), at 37C for 1 h. The labeled
cells were rinsed and then marked by secondary antibodies
[Beyotime, A0562, FITC-labeled goat anti-rabbit IgG (H+L);
Beyotime, A0568, FITC-labeled goat anti-mouse IgG (H+L)]
at 37C for 20 min. The unlabeled cells were analyzed in
parallel. Cells were examined using flow cytometry with
FACSCalibur (BD) following standard procedures.
Hypoxic culture and application of a compression
apparatus
The compression apparatus, where cells were cultured
inside, was an incubation chamber used to simulate the load
on human lumbar discs, as we previously described [18,32–
34]. BMSCs seeded on cell culture plates were placed into
the chamber and then exposed to 1.0 MPa mechanical
compression for 12, 24, 36, and 48 h. The whole apparatus
was placed into a thermotank at 37C. Besides, the con-
centration of CO2 was maintained at 5%, monitored by a
CO2 indicator. Control cells were cultured in the absence of
compression under the same culture conditions.
Cobalt chloride (CoCl2; Sigma, United Kingdom) is a
widely acknowledged chemical inducer of hypoxia. BMSCs
were cultured in fresh complete medium, treated with dif-
ferent concentrations of CoCl2 (0, 1, 10, 30, 50, 100, and
200 mM), and then exposed to compression for 12, 24, 36,
and 48 h. The control group (0mM) was cultured in the
absence of compression under the same culture conditions.
Additionally, the HIF-1a inhibitor chetomin (CHT, Selleck)
and YAP inhibitor verteporfin (VP, MCE) were applied to
cells 1 h before hypoxic culture, respectively.
Cell viability assay
Cell viability was measured using the cell counting kit-8
(CCK-8, Dojindo, Japan), following the manufacturer’s in-
structions. BMSCs were seeded at a density of 5 · 103 cells/well















































into 96-well plates. After exposure to compression and CoCl2
with different concentrations for 12, 24, 36, and 48 h, 90mL
of medium and 10mL of CCK-8 solution were added to each
well and the plate was maintained at 37C for 2 h in the dark.
The optical density (OD) values at 450 nm were measured
using a spectrophotometer (BioTek).
Annexin V/PI staining
The apoptosis rate of BMSCs was determined using an
Annexin V-FITC Apoptosis Detection Kit (KeyGen Bio-
tech, China). After treatment, cells were harvested by
trypsinization, washed twice in PBS, and resuspended in
200 mL of binding buffer. Next, 5 mL of Annexin V and 5mL
of PI were added to the suspensions and subsequently ana-
lyzed by flow cytometry (BD LSR II), and data were ana-
lyzed using FlowJo, V10, software. The apoptosis rate was
calculated as the sum of early apoptotic (Annexin V+ PI-)
cells and late apoptotic (Annexin V+ PI+) cells.
Mitochondrial membrane potential assay
Mitochondrial membrane potential (MMP) was measured
with the JC-1 fluorescent probe (Beyotime, China). Cells
were incubated with a 500mL working solution for 20 min at
37C. After rinsing twice with precooling buffer solution,
cells were resuspended in medium and analyzed by flow
cytometry. Mitochondria with higher potential were labeled
with red fluorescence produced by JC-1 aggregates. The
lower potential mitochondria, which indicated an early stage
of apoptosis, were labeled with green fluorescence produced
by JC-1 monomers. The MMP was expressed as the ratio of
red fluorescence intensity to green fluorescence intensity.
TUNEL staining
Apoptotic cells were detected using the One Step TUNEL
Apoptosis Assay Kit (Beyotime, China). After incubating
with the TUNEL reagent in the dark for 1 h at 37C, cells
were stained with 4¢,6-diamidino-2-phenylindole (DAPI,
Solarbio, China) for 5 min. Apoptotic cells showed red
fluorescence (Cy3 labeled). Images of multiple cells from
three independent experiments were obtained with a fluo-
rescence inversion microscope (Olympus, Japan).
Western blot analysis
After treatments, the total protein of BMSCs was
extracted by RIPA buffer (Beyotime, #P0013D, China)
containing 1% phenylmethanesulfonyl fluoride (PMSF,
FIG. 1. Identification of BMSCs. (A) Alizarin Red, Oil Red O, and Alcian Blue staining were used to detect the
osteogenic, adipogenic, and chondrogenic differentiation potential of BMSCs. Scale bar, 200mm. (B) Surface markers of
first passage BMSCs were detected by flow cytometry. Red curves indicate the percentage of labeled BMSCs and blue
curves represent the blank control. (C) Positive rates of CD105, CD90, CD73, CD45, CD34, and HLA-DR, results are
shown as mean – SD. BMSC, bone marrow mesenchymal stem cell. Color images are available online.















































Beyotime, China) and phosphorylase inhibitor (Servicebio,
China). Protein concentration was determined using a BCA
protein assay kit (Beyotime). Then, cell lysates were sepa-
rated by SDS-PAGE (Beyotime) and transferred to PVDF
membranes (Millipore). Blots were incubated overnight at
4C with the following primary antibodies: HIF-1a (1:500,
Novus, NB100-105), caspase-3 (1:1000, Proteintech, 19677-
1-AP), Bcl-2 (1:1000, Abcam, ab196495), Bax (1:1000,
CST, #2772), YAP (1:1000, CST, #14074), p-YAP Ser127
(1:1000, CST, #13008), and b-actin (1:1000, CST, #3700).
Immunoblotting was detected using the UVP ChemiDoc-It
Imaging System and enhanced chemiluminescence detec-
tion kit (Affinity; KF003).
Immunofluorescence
Cells cultured in six-well plates were rinsed three times
with phosphate-buffered saline (PBS) and fixed in 4%
polyformaldehyde for 15 min. After permeabilization with
0.5% Triton X-100 for 10 min, cells were blocked with 0.1%
BSA for 30 min at room temperature. The cells were incu-
bated with the primary antibody (HIF-1a, 1:200, Novus,
NB100-105) overnight at 4C. After rinsing, cells were in-
cubated with Cy3-conjugated goat anti-mouse IgG (H+L)
(1:100, Boster, BA1031) for 1 h at room temperature. Fol-
lowing rinsing with PBS, cells were blocked with 0.1% BSA
again and incubated with the primary antibody (YAP, 1:200,
CST, #14074) and the secondary antibody FITC-conjugated
goat anti-rabbit IgG (H+L) (1:100, Boster, BA1105). We
counterstained the cells using DAPI (Solarbio, C0065,
China) and visualized them under a fluorescence microscope
(Olympus, Japan).
Coimmunoprecipitation
Cells were lysed in RIPA buffer supplemented with 1%
PMSF. Cell lysates were incubated with an equal amount of
primary Rabbit anti-YAP antibody (5mL, CST, #14074) or
IgG at 4C overnight before performing the pull-down assay
with 20 mL of protein A + G agarose (Beyotime; #P2012) for
2 h. Beads were washed four times with lysis buffer, boiled,
and the supernatant was subjected to SDS-PAGE and
western blotting.
Statistical analysis
Statistical analysis was conducted using GraphPad Prism
7 software (GraphPad Software, Inc.). All data are presented
as mean – standard deviation (SD) from at least three inde-
pendent experiments. Multiple sets of data were analyzed by
one-way or two-way ANOVA, followed by Tukey’s post
hoc test. Student’s t tests were performed to analyze the
differences between two groups. Statistical significance was
set at P < 0.05.
FIG. 2. The effect of CoCl2 and compression on BMSC viability. (A) The CCK-8 assay was used to detect the cyto-
toxicity of CoCl2 for different concentrations on BMSCs. (B) The cell viability of BMSCs treated with compression and
different concentrations of CoCl2 for 12, 24, 36, and 48 h was detected. Results are shown as mean – SD. P values are
labeled in numbers in the statistical chart. (C) Western blot analysis assessed the hypoxic simulation effect of CoCl2 with
different concentrations for 48 h. b-Actin served as the internal control. (D) Densitometric analysis of the relative HIF-1a
level is shown in the statistical chart (normalized to 0 mM, CoCl2 group). Results are shown as mean – SD and P values are
indicated in numbers in the statistical chart.















































FIG. 3. CoCl2-simulated hypoxia alleviated compression-induced BMSC apoptosis. (A) Flow cytometry analysis of
Annexin V/PI double staining was used to detect the apoptosis rate of BMSCs treated with 48-h compression and 30 mM
CoCl2. (B) Quantitative analysis of the apoptosis rate is shown as mean – SD. P values are indicated in numbers in the
statistical chart. HP, hypoxia. (C) JC-1 staining was used to detect MMP changes in BMSCs by flow cytometry. The MMP
level is expressed as the ratio of red fluorescence intensity ( JC-1 aggregates) to green fluorescence intensity ( JC-1
monomers). (D) Quantitative analysis of the red/green ratio is shown in the statistical chart. (E) Western blot analysis of
HIF-1a and apoptosis-related proteins in BMSCs treated with compression and HP. (F) Densitometric analysis of the
relative apoptosis-related protein level (normalized to the control group). Results are shown as mean – SD and P values are
indicated in numbers in the statistical chart. MMP, mitochondrial membrane potential; HIF-1a, hypoxia inducible factor 1


















































The isolated BMSCs could be effectively induced into
osteogenic, adipogenic, and chondrogenic differentiation,
respectively (Fig. 1A). Meanwhile, flow cytometric analysis
showed that BMSCs expressed stem cell markers, including
CD73, CD90, and CD105 (positive rate >95%), and were
negative for CD34, CD45, and HLA-DR (positive rate <2%)
(Fig. 1B, C).
Effect of CoCl2 and compression on BMSC viability
CoCl2 suppresses prolyl hydroxylation and pVHL-
mediated degradation of HIF-1a, thus stabilizing the
expression of HIF-1a and simulating hypoxic conditions
[35]. CoCl2 showed no significant cytotoxicity up to 100mM
on BMSCs (Fig. 2A). To establish the overloaded and
hypoxic microenvironment of IVDs in vitro, cells were ex-
posed to various concentrations of CoCl2 and 1.0 MPa
compression for 12, 24, 36, and 48 h. The CCK-8 assay
was performed to determine the effect of compression and
hypoxia on viability of BMSCs. Cell viability decreased
significantly under compression in a time-dependent man-
ner. Treatment with 30 mM CoCl2 reversed the inhibitory
effect of compression on cell viability, which was most
apparent at 48 h (P < 0.001) (Fig. 2B). In addition, the ex-
pression level of HIF-1a at 48 h was detected to explore the
simulation effect of CoCl2 on BMSCs. Our data indicated
that HIF-1a exhibited a notably altered and stable expres-
sion pattern with 30mM CoCl2 as the minimum effective
concentration (Fig. 2C, D).
FIG. 4. HIF-1a mediated the antiapoptotic effect of BMSCs under compression. (A) The CCK-8 assay was used to detect
cell viability of BMSCs treated with CHT and HP under compression. (B) TUNEL staining (red signal) was used to detect
apoptotic changes in BMSCs treated with CHT and HP under compression. The nucleus was labeled with DAPI. The white
arrowhead indicates the TUNEL-positive cell. Scale bar, 200mm. (C) Quantitative analysis of the TUNEL-positive rate is
shown in the statistical chart. (D) Western blot analysis showed expression of apoptosis-related proteins in BMSCs treated
with CHT and HP under compression. The densitometric analysis is shown in the statistical chart (normalized to the
compression group). Results are shown as mean – SD and P values are indicated in numbers in the statistical chart. CCK-8,
cell counting kit-8. Color images are available online.
‰
FIG. 5. Hypoxia exerted protective effects through activation of the HIF-1a/YAP signaling pathway. (A) Western blot
analysis showed expression levels of YAP and p-YAP with CHT treatment under compression and hypoxia. (B) The
densitometric analysis of the relative ratio p-YAP/YAP is shown in the statistical chart (normalized to the compression
group). Results are shown as mean – SD. (C) Western blot analysis of HIF-1a, YAP, p-YAP, Bax, and cleaved caspase-3
with VP treatment under compression and hypoxia. (D) The densitometric analysis is shown in the statistical chart. (E)
Immunofluorescence staining of HIF-1a (red) and YAP (green) in BMSCs treated with VP under compression and hypoxia.
The nucleus is labeled with DAPI. Scale bar, 20mm. (F) Co-IP assay of endogenous YAP and HIF-1a in BMSCs under
hypoxia and compression. YAP, yes-associated protein. Color images are available online.
































































































The Annexin V/PI apoptosis assay showed that 48-h
compression significantly increased the apoptosis rate com-
pared with the control group. However, CoCl2-simulated
hypoxia (HP) alleviated the apoptosis rate of BMSCs
compared with the compression group (14.36% – 1.60% in
the compression+HP group vs. 29.02% – 3.45% in the
compression group, P < 0.001) (Fig. 3A, B). To further ex-
plore the effect of HP and compression on BMSC apoptosis,
MMP was detected with a fluorescent probe, JC-1. MMP
loss reflects mitochondrial dysfunction and is generally
perceived as an early sign of apoptosis. MMP loss was
observed in the compression group, as indicated by the
decreased red/green fluorescence ratio, while HP restored
compression-induced MMP loss (P < 0.01) (Fig. 3C, D).
Western blot results showed that the antiapoptosis protein,
Bcl-2, was downregulated, while the proapoptosis proteins,
Bax and cleaved caspase-3, increased under compression.
However, the mitochondrial apoptotic pathway was signif-
icantly inhibited by HP (Fig. 3E, F). These results showed
that HP alleviated compression-induced BMSC apoptosis
through the mitochondrial apoptotic pathway.
HIF-1a mediated the antiapoptotic effect
of BMSCs under compression
To investigate whether the antiapoptotic effect was HIF-
1a dependent, we used chetomin (CHT, 50 nM), a protein
that inhibits the transcriptional activity of HIF-1a. CHT
disrupts the structure of the CH1 domain of p300 coacti-
vator, which precludes its interaction with the C-terminal
transactivation domain of HIF-1a, inhibiting hypoxia in-
ducible transcription activation [36]. Cell viability de-
creased remarkably with the CHT treatment, and no
significant difference was observed between CHT and
HP+CHT groups (Fig. 4A). Moreover, CHT blocked the
antiapoptotic effect of HP under compression, indicated by
the elevated TUNEL-positive rate (17.41% – 2.45% in the
HP+CHT group vs. 2.99% – 1.07% in the HP group under
compression, P < 0.001) and increased brightly stained con-
densed nuclei (Fig. 4B, C). Increased protein levels of
Bax and cleaved caspase-3, along with a decreased level of
Bcl-2, were observed in the presence of CHT (Fig. 4D). In
summary, these results demonstrated that the antiapoptotic
effect of HP under compression was mediated by HIF-1a.
Hypoxia exerted protective effects through
activation of the HIF-1a/YAP signaling pathway
YAP is crucial to stem cell survival in tissue regeneration.
Thus, the association between HIF-1a and YAP and their
roles in protecting BMSCs against compression-induced
apoptosis were investigated. Both p-YAP (Ser127) and the
ratio of p-YAP/YAP reduced in hypoxia, while increased
accumulation of p-YAP was observed when CHT was ap-
plied. It implied that hypoxia-induced YAP activation was
dependent on the transcriptional activity of HIF-1a (Fig. 5A,
B). We used verteporfin (VP, 10 nM), an FDA-approved
YAP-selective inhibitor, to inhibit the expression of YAP
and disturb the interaction between YAP and several DNA-
binding transcription factors [37,38]. VP treatment de-
creased both YAP and p-YAP expression. Meanwhile, VP
abrogated the antiapoptotic effect of hypoxia and upregu-
lated the expression of proapoptotic proteins, which dem-
onstrated the essential role of YAP in compression-induced
apoptosis (Fig. 5C, D). Taken together, these results re-
vealed that hypoxia exerted protective effects on BMSCs
under compression through activation of the HIF-1a/YAP
signaling pathway.
Considering that YAP nuclear translocation is the key
regulatory mechanism for YAP activation, we performed
immunofluorescence staining to examine the interaction and
localization of HIF-1a and YAP in hypoxia and compres-
sion. HIF-1a and YAP were both activated and colocalized
in the nucleus under hypoxia, while YAP maintained cyto-
plasmic retention and phosphorylated under compression
without hypoxia. Additionally, VP blocked YAP from
translocating into the nucleus in hypoxia (Fig. 5E). As a
transcriptional coactivator, YAP was activated by and co-
localized with HIF-1a. Thus, we further speculated that
YAP could bind to HIF-1a in hypoxia. Coimmunopreci-
pitation (Co-IP) assay confirmed that YAP could directly
interact with HIF-1a (Fig. 5F). Thus, HIF-1a recruited and
bound to YAP in hypoxia, thereby forming a complex in the
nucleus and transactivating target genes responsible for
cellular survival (Fig. 6).
FIG. 6. The schematic diagram shows the
effect of a hypoxic and overloaded disc
microenvironment on transplanted bone
marrow mesenchymal stem cells for IVD
regeneration. In hypoxia, HIF-1a recruits
and binds to YAP, thereby forming a com-
plex in the nucleus and transactivating target
genes responsible for cellular survival. IVD,
intervertebral disc. Color images are avail-
able online.
















































In the current study, we evaluated the effects of hyp-
oxia and compression on BMSCs and investigated the
mechanism underlying these effects. Importantly, hypoxia
could protect BMSCs against compression-induced apo-
ptosis through inhibition of the mitochondrial apoptotic
pathway. Our research revealed that the antiapoptotic effect
of hypoxia was mediated by HIF-1a. As hypoxia triggered
YAP activation, we hypothesized that HIF-1a recruited and
bound to YAP in the nucleus, inducing the expression of
target genes responsible for cell survival.
Major advances have been made in stem cell therapy for
IVDD [39]. However, the degenerative disc microenviron-
ment, mainly characterized by excessive mechanical loading
and hypoxia, remains an obstacle for the long-lasting sur-
vival of transplanted mesenchymal stem cells. In particular,
excessive mechanical loading plays a crucial role in the
progression of IVDD [40]. Previous studies have shown the
proapoptotic effects of compression on NP cells and NP
progenitor/stem cells [18,32]. Similarly, our results showed
that compression not only reduced BMSC viability but also
induced apoptosis through the mitochondrial apoptotic
pathway [18]. Furthermore, we found that hypoxia could
alleviate compression-induced apoptosis by reducing MMP
loss and restoring mitochondrial function. These results
suggested that hypoxia was beneficial for transplanted
BMSC survival. Cells that reside in the hypoxic niche of
healthy IVDs of mammals showed stable expression of
HIF-1a [41]. It has been previously demonstrated that
HIF-1a played a vital role in cell survival and ECM ho-
meostasis during IVDD [21]. In our in vitro experiment, the
control group and compression group were exposed to
normoxic conditions. In the presence of oxygen, HIF-1a was
degraded through the proteasome and prolyl hydroxylases in
an oxygen-dependent manner [42], which resulted in a
nonsignificant effect of compression alone on HIF-1a levels.
Under hypoxic conditions, HIF-1a is stabilized and ac-
cumulates in the nucleus where it triggers transcriptional
activation [43]. Under CHT stimuli, the reduced cell via-
bility and increased TUNEL-positive rate were not reversed
by HP treatment, indicating that the antiapoptotic effect was
dependent on the transcriptional activity of HIF-1a. More-
over, CHT reversed the inhibitory effect of HP on the
mitochondrial apoptotic pathway. Thus, we confirmed that
the antiapoptotic effect of hypoxia was mediated by HIF-1a.
Previous studies have also shown that hypoxic mesenchymal
stem cells exhibited a high capacity for ECM synthesis and
high migration ability, both of which are also HIF-1a
dependent [44,45]. Additionally, neovascularization with
increased oxygen concentration may occur in severely de-
generated discs [46], which may contribute to the compro-
mised efficacy of stem cell therapy in patients with severe
disc degeneration.
In the present study, we demonstrated that hypoxia pro-
moted BMSC survival under compression by upregulating
YAP expression and triggering its nuclear translocation.
CHT treatment blocked hypoxia-induced YAP recruitment
into the nucleus and its activation, which implied that YAP
activation was mediated by HIF-1a. VP disrupted the ac-
tivity of YAP as a transcriptional coactivator and promoted
YAP degradation, along with elevated proapoptotic protein
levels, suggesting that YAP activation was essential for the
prosurvival effect of hypoxia. As a transcriptional coacti-
vator, YAP was activated by and colocalized with HIF-1a.
A co-IP assay revealed that YAP could bind to HIF-1a
under compression and hypoxic conditions. Taken together,
HIF-1a recruits and binds to YAP in hypoxia, thereby
forming a complex in the nucleus and transactivating target
genes responsible for cellular survival. However, the spe-
cific target genes activated by the HIF-1a/YAP complex
require further study.
In conclusion, our study demonstrated the protective ef-
fect of hypoxia against compression-induced apoptosis of
BMSCs through activation of HIF-1a/YAP signaling and
revealed the adaptive mechanism of BMSCs to hypoxia in a
degenerative disc microenvironment. Further studies should
explore the long-term survival of transplanted BMSCs
overexpressing HIF-1a or YAP in animal models. Mean-
while, the target genes upregulated by the HIF-1a/YAP
complex require further investigation. Future preclinical
trials and animal experiments using HIF-1a- or YAP-
overexpressing BMSCs for intradiscal injection may provide
a therapeutic strategy for optimizing stem cell therapy in
IVDD treatment.
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